Protein Adsorption onto Nanosized Hydroxyapatite Particles for Controlled Drug Release

Nanosized hydroxyapatite(nsHAp) was synthesized to examine its possibility as a controlled release carrier of protein. To achieve effective protein release from nanosized hydroxyapatite, the study of the adsorptive properties of protein on nsHAp and different influence parameters such as pH, calcium, and phosphate concentrations during the adsorption process is necessary. Ovalbumin(OVA) was selected as the model of growth factors. The results show that the amount of OVA adsorbed onto nsHAp in acetic buffer(pH=3.6) is more than that in acetic buffer(pH=5.6) because of the electric interaction. The amount of OVA adsorption in phosphate buffer solution(PBS) is smaller than that in acetic buffer because of surface complexation and surface hydroxylation. The presence of Ca2 dramatically increases the adsorbed amount of OVA in acetic buffer on maintaining the same pH. Meanwhile, the release kinetics of OVA adsorbed onto nsHAp(nsHAp-OVA) was also examined. The amount of released OVA in PBS(pH=5.6) was significantly smaller than that released in solution of pH=7.0. All the results suggest that nanosized hydroxyapatite particles could be successfully used as controlled released carrier of protein.     

PVP-semi-IPN-PCL/PLA水凝胶制备及负载卡马西平药物共晶体外释放

通过N-乙烯基吡咯烷酮(N-vinyl pyrrolidone, NVP)在聚己内酯(polycaprolactone, PCL)、聚乳酸(poly(lactic acid),PLA)乙酸乙酯溶液中自由基聚合,制得聚乙烯吡咯烷酮(Polyvinylpyrrolidone, PVP)/聚己内酯、聚乳酸半互穿网络(semi-interpenetrating network, semi-IPN)水凝胶(PVP-semi-IPN-PCL/PLA)。实验制得疏水/亲水比例分别为1∶9、3∶7、5∶5的三种水凝胶。采用溶剂挥发法制备卡马西平-丁二酸药物共晶(carbamazepine-succinic acid, CBZ-SUC)。使用PVP-semi-IPN-PCL/PLA负载CBZ-SUC共晶,考察上述三种凝胶药物载体的载药能力及体外释放行为。使用1∶9、3∶7、5∶5比例凝胶制备了载药量分别为17%、19%、21%,包封率分别为71%、83%、89%的载药凝胶,其在37℃,pH=6.8 PBS溶液中体外释放效果均优于未使用凝胶载体的CBZ-SUC共晶。其中,3∶7组载药凝胶的累积释放量最高,...     

pH/温度双重敏感性微凝胶的合成与应用

智能微凝胶是一类具有独特物理、化学性质的聚合物网络和溶剂组成的体系, 在众多的领域具有潜在的应用.本文介绍了近年来pH和温度双重敏感性微凝胶的研究概况、制备方法及其在药物控制释放、分离纯化和光子晶体方面的应用.     

基于碳水化合物的阳离子聚合物载体在基因释放中的应用

在基因治疗中,基因释放载体是不可缺少的重要组成部分.近几年来聚合物基因释放载体的研究主要旨在开发低毒或无毒的阳离子聚合物用于安全有效的基因释放.作为一类天然化合物,基于碳水化合物的阳离子聚合物载体由于其良好的生物相容性和低毒性被广泛地研究并应用于基因释放.本文阐述了聚合物基因释放的机理,并对近几年来一些典型的含碳水化合物的阳离子聚合物基因释放载体作一综述.     

温敏性聚膦腈及其在药物释放体系中的应用

温敏性聚合物能通过感知温度而实现环境响应,作为药剂可依靠对此类信号的自反馈响应而释放药物或中止释放,极大地增强了释药的持续性和专一性,从而提高了药物的药效和安全性.温敏性聚膦腈是一类新型的温敏材料,它具有良好的生物可降解性质,优良的生物相容性.因此,温敏性聚膦腈作为药物载体用于药物释放体系具有很好的应用前景,近年来备受关注.本文对聚膦腈的温敏性质、生物降解性质进行了评述,并探讨了LCST的影响因素,以及在药物释放体系的应用进展.     

分子印迹智能水凝胶的研究进展

智能水凝胶可以响应外界环境(如温度、pH、溶剂、离子强度、电场、磁场、光、压力和特异分子等)的变化,发生可逆体积相变,从而具有控制释放的能力.将分子印迹技术引入智能水凝胶,制备分子印迹智能水凝胶,不仅可以保持其环境响应性,更赋予其对特异分子的识别性能,从而可以根据外界环境的变化控制其对特定分子记忆功能的开关,实现自动识别并结合或释放特定分子.它有望应用于药物控释、生物传感和免疫分析等领域.本文综述了分子印迹智能水凝胶的研究现状,讨论了其目前所面临的挑战,并展望了其发展前景.     

光纤过程检测硫酸亚铁缓释片释放度

建立光纤药物溶出度实时测定仪（FODT）在线监测硫酸亚铁溶出度测定的新方法.研究发现通过络合反应检测Fe2＋是可行的,FODT测定硫酸亚铁缓释片释放度与AAS测定结果无统计学意义.利用FODT过程检测硫酸亚铁缓释片释放度,全面直观地反映了药品的释放过程和内在质量,较经典方法能提供更多信息,测定过程简便自动,测定结果准确可靠.     

Parametric resonance and cooling on an atom chip

This paper observes the parametric excitation on atom chip by measuring the trap loss when applying a parametric modulation. By modulating the current in chip wires, it modulates not only the trap frequency but also the trap position. It shows that the strongest resonance occurs when the modulation frequency equals to the trap frequency. The resonance amplitude increases exponentially with modulation depth. Because the Z-trap is an anharmonic trap, there exists energy selective excitation which would cause parametric cooling. We confirm this effect by observing the temperature of atom cloud dropping.     

二次喉道扩压器对COIL的影响实验

 氧碘化学激光器分别采用二次喉道扩压器和8°扩压器时，对在不同阀门开度下的气流方向的壁面静压曲线和背压曲线，光轴壁面静压曲线，出口总压与上游压比值曲线，输出功率曲线进行了测量。对两种扩压器的数据进行了对比，结果表明：与8°扩压器相比，二次喉道扩压器能够有效隔离扩压器下游气流对光腔的干扰，显著减小捩区长度，并将转捩区控制在扩压器内。在激光器背压升高时，二次喉道扩压器的稳定性更强。